HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
NXN-188
Description
NXN-188 is a first-in-class, dual-action small molecule incorporating both neuronal nitric oxide synthase (nNOS) inhibition and 5-HT agonism that is being developed for the treatment of acute migraine.
No brand information found.
